Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
暂无分享,去创建一个
Olle Ljunqvist | D. Moller | L. Goodyear | Gaochao Zhou | N. Musi | M. Hirshman | O. Rooyackers | P. Båvenholm | S. Efendić | J. Nygren | A. Thorell | J. Williamson | Nicolas Musi | Michael F Hirshman | Jonas Nygren | Monika Svanfeldt | Peter Bavenholm | Olav Rooyackers | Gaochao Zhou | Joanne M Williamson | Suad Efendic | David E Moller | Anders Thorell | Laurie J Goodyear | M. Svanfeldt | O. Ljunqvist
[1] J. Fisher,et al. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. , 2002, American journal of physiology. Endocrinology and metabolism.
[2] B. Kemp,et al. Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.
[3] M. Vincent,et al. Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat Hepatocytes , 1991, Diabetes.
[4] R. Kelsey,et al. Separation of taxol from related taxanes in Taxus brevifolia extracts by isocratic elution reversed-phase microcolumn high-performance liquid chromatography , 1991 .
[5] Margaret S. Wu,et al. Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.
[6] D. Hardie,et al. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. , 2000, Diabetes.
[7] M. Goalstone,et al. The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes. , 1996, Endocrinology.
[8] H. Klein,et al. In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. , 1993, Endocrinology.
[9] O. Ljungqvist,et al. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.
[10] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[11] N. Wiernsperger,et al. Stimulation of the intracellular portion of the human insulin receptor by the antidiabetic drug metformin. , 1998, Biochemical pharmacology.
[12] R. DeFronzo,et al. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. , 1990, Metabolism: clinical and experimental.
[13] W. Winder,et al. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. , 1999, Journal of applied physiology.
[14] J. Zierath,et al. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM , 1994, Diabetologia.
[15] G. Shulman,et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.
[16] O. Ljungqvist,et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. , 2001, Diabetes.
[17] D. Hardie,et al. AMP-Activated Protein Kinase , 2017, Encyclopedia of Molecular Pharmacology.
[18] C. Bailey,et al. Accumulation of metformin by tissues of the normal and diabetic mouse. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.
[19] G. Shulman,et al. Effect of AMPK activation on muscle glucose metabolism in conscious rats. , 1999, American journal of physiology. Endocrinology and metabolism.
[20] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[21] D. Hardie,et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.
[22] M. Kiln. Effects of intensive blood-glucose control. , 1993, Lancet.
[23] B. Hansen,et al. Isoform‐specific and exercise intensity‐dependent activation of 5′‐AMP‐activated protein kinase in human skeletal muscle , 2000, The Journal of physiology.
[24] G. Reaven,et al. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance. , 1997, Diabetes & metabolism.
[25] B. Kemp,et al. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. , 1992, The Journal of biological chemistry.
[26] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[27] R. DeFronzo,et al. Metformin: A review of its metabolic effects , 1998 .
[28] H. Beck-Nielsen,et al. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. , 1989, Acta endocrinologica.
[29] M. Rigoulet,et al. Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.
[30] G. Shulman,et al. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. , 2001, Diabetes.
[31] O. Pedersen,et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. , 2001, Diabetes.
[32] H. Rüdiger,et al. Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. , 1981, The New England journal of medicine.
[33] S. Hawley,et al. Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.
[34] M. Carlson,et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.
[35] B. Rasmussen,et al. Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. , 1998, Journal of applied physiology.
[36] D. Küry,et al. Trimethylsilyl-O-methyloxime derivatives for the measurement of [6,6-2H2]-D-glucose-enriched plasma samples by gas chromatography-mass spectrometry. , 1991, Journal of chromatography.
[37] References , 1971 .
[38] G. Reaven,et al. Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients , 1990, Diabetes Care.
[39] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[40] D. Carling,et al. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. , 1989, European journal of biochemistry.
[41] I. G. Fantus,et al. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. , 1986, The Journal of clinical endocrinology and metabolism.
[42] M. Owen,et al. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.
[43] S. Mudaliar,et al. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. , 2002, Diabetes.
[44] C. Bailey,et al. Effect of metformin on glucose metabolism in mouse soleus muscle. , 1986, Diabete & metabolisme.
[45] W. Winder,et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. , 2000, Journal of applied physiology.
[46] Lawrence A Leiter,et al. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. , 1992, The Journal of clinical investigation.
[47] J. Olefsky,et al. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. , 1999, Diabetes.
[48] O. Ljungqvist,et al. Site of insulin resistance after surgery: the contribution of hypocaloric nutrition and bed rest. , 1997, Clinical science.
[49] Tatsuya Hayashi,et al. Evidence for 5′AMP-Activated Protein Kinase Mediation of the Effect of Muscle Contraction on Glucose Transport , 1998, Diabetes.
[50] J. Lord,et al. Postreceptor effect of metformin on insulin action in mice , 1985, The Journal of pharmacy and pharmacology.
[51] N. Fujii,et al. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. , 2001, American journal of physiology. Endocrinology and metabolism.
[52] L. C. Clark,et al. Rapid micromeasurement of lactate in whole blood. , 1984, Critical care medicine.
[53] K. Petersen,et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. , 2000, Diabetes.
[54] N. Wollen,et al. Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. , 1988, Biochemical pharmacology.
[55] G Dailey,et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[56] Lawrence A Leiter,et al. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. , 1992, Endocrinology.
[57] M. Bucan,et al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.
[58] during exercise in , 2022 .
[59] D. Carling,et al. Dual regulation of the AMP‐activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle , 1998, The EMBO journal.
[60] R. Bergman,et al. Modeling Error and Apparent Isotope Discrimination Confound Estimation of Endogenous Glucose Production During Euglycemic Glucose Clamps , 1988, Diabetes.
[61] O. Ljungqvist,et al. Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. , 2000, Biochemical and biophysical research communications.
[62] D. Hardie,et al. The AMP-activated protein kinase--fuel gauge of the mammalian cell? , 1997, European journal of biochemistry.
[63] B. Kemp,et al. Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.
[64] D. Hardie,et al. AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.
[65] Martin M. Matzuk,et al. Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.